FIELD: medicine.
SUBSTANCE: essence of the invention lies in a composition which, after introduction to an individual, is capable of inducing a humoral immune response at the given individual the humoral immune response performing bactericidal effect against two or three of supervirulent rows of generations A4, ET5 and a number of generations of the 3rd serogroup in N.meningitidis. of an external membrane. Five albuminous antigens are used, i.e. (1) protein "NadA"; (2) protein "741"; (3) protein "936"; (4) protein of "953" and (5) protein "287".
EFFECT: development of a vaccine against two or more rows of supervirulent meningococcus generations.
29 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
LIQUID VACCINES FOR MULTIPLE MENINGOCOCCAL SEROGROUPS | 2004 |
|
RU2378010C2 |
LIQUID VACCINE FOR MULTIPLE SEROGROUPS OF MENINGOCOCCUS | 2009 |
|
RU2595845C2 |
HYPO- AND HYPERACETILATED MENINGOCOCCAL CAPSULAR SACCHARIDES | 2004 |
|
RU2362784C2 |
FACTOR H-BINDING ADJUVANT MENINGOCOCCAL PROTEIN | 2010 |
|
RU2557315C2 |
VACCINES FOR SEROGROUP X MENINGOCOCCUS | 2013 |
|
RU2644340C2 |
MULTIPLE VERSIONS OF MENINGOCOCCAL PROTEIN NMB 1870 | 2003 |
|
RU2336091C2 |
IMPROVEMENTS DEALING WITH MENINGOCOCCUS OUTER MEMBRANE VESICLES | 2005 |
|
RU2420312C2 |
MENINGOCOCCAL fHBP POLYPEPTIDES | 2009 |
|
RU2475496C2 |
COMBINATIONS OF MENINGOCOCCAL FACTOR-H-BINDING PROTEIN AND PNEUMOCOCCAL SACCHARIDE CONJUGATES | 2010 |
|
RU2555757C2 |
HYBRID AND TANDEM EXPRESSION OF NEISSERIAL PROTEINS | 2002 |
|
RU2475495C2 |
Authors
Dates
2008-09-10—Published
2003-10-02—Filed